168 related articles for article (PubMed ID: 32791399)
1. Design, synthesis and bioactivity evaluation of novel arylalkene-amide derivatives as dual-target antifungal inhibitors.
Sun B; Dong Y; An Y; Liu M; Han J; Zhao L; Liu X
Eur J Med Chem; 2020 Nov; 205():112645. PubMed ID: 32791399
[TBL] [Abstract][Full Text] [Related]
2. Novel naphthylamide derivatives as dual-target antifungal inhibitors: Design, synthesis and biological evaluation.
An Y; Dong Y; Liu M; Han J; Zhao L; Sun B
Eur J Med Chem; 2021 Jan; 210():112991. PubMed ID: 33183866
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of amide-pyridine derivatives as novel dual-target (SE, CYP51) antifungal inhibitors.
Sun B; Dong Y; Lei K; Wang J; Zhao L; Liu M
Bioorg Med Chem; 2019 Jun; 27(12):2427-2437. PubMed ID: 30765301
[TBL] [Abstract][Full Text] [Related]
4. Construction and activity evaluation of novel dual-target (SE/CYP51) anti-fungal agents containing amide naphthyl structure.
Liu W; Sun Z; An Y; Liu Y; Fan H; Han J; Sun B
Eur J Med Chem; 2022 Jan; 228():113972. PubMed ID: 34772530
[TBL] [Abstract][Full Text] [Related]
5. Potent arylamide derivatives as dual-target antifungal agents: Design, synthesis, biological evaluation, and molecular docking studies.
Dong Y; Liu X; An Y; Liu M; Han J; Sun B
Bioorg Chem; 2020 Jun; 99():103749. PubMed ID: 32220664
[TBL] [Abstract][Full Text] [Related]
6. Construction and activity evaluation of novel benzodioxane derivatives as dual-target antifungal inhibitors.
An Y; Liu W; Xie H; Fan H; Han J; Sun B
Eur J Med Chem; 2022 Jan; 227():113950. PubMed ID: 34731761
[TBL] [Abstract][Full Text] [Related]
7. Comparison and analysis of the structures and binding modes of antifungal SE and CYP51 inhibitors.
Sun B; Huang W; Liu M; Lei K
J Mol Graph Model; 2017 Oct; 77():1-8. PubMed ID: 28802152
[TBL] [Abstract][Full Text] [Related]
8. Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans.
Binjubair FA; Parker JE; Warrilow AG; Puri K; Braidley PJ; Tatar E; Kelly SL; Kelly DE; Simons C
ChemMedChem; 2020 Jul; 15(14):1294-1309. PubMed ID: 32459374
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and antifungal activity of some new imidazole and triazole derivatives.
Rezaei Z; Khabnadideh S; Zomorodian K; Pakshir K; Kashi G; Sanagoei N; Gholami S
Arch Pharm (Weinheim); 2011 Oct; 344(10):658-65. PubMed ID: 21984016
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Antifungal Activity Evaluation of New Thiazolin-4-ones as Potential Lanosterol 14α-Demethylase Inhibitors.
Stana A; Vodnar DC; Tamaian R; Pîrnău A; Vlase L; Ionuț I; Oniga O; Tiperciuc B
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106743
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of benzotriazole derivatives as novel antifungal agents.
Shah JJ; Khedkar V; Coutinho EC; Mohanraj K
Bioorg Med Chem Lett; 2015 Sep; 25(17):3730-7. PubMed ID: 26117563
[TBL] [Abstract][Full Text] [Related]
12. Design and optimization of highly-selective fungal CYP51 inhibitors.
Hoekstra WJ; Garvey EP; Moore WR; Rafferty SW; Yates CM; Schotzinger RJ
Bioorg Med Chem Lett; 2014 Aug; 24(15):3455-8. PubMed ID: 24948565
[TBL] [Abstract][Full Text] [Related]
13. Nitrate Esters of Heteroaromatic Compounds as Candida albicans CYP51 Enzyme Inhibitors.
Smiljkovic M; Matsoukas MT; Kritsi E; Zelenko U; Grdadolnik SG; Calhelha RC; Ferreira ICFR; Sankovic-Babic S; Glamoclija J; Fotopoulou T; Koufaki M; Zoumpoulakis P; Sokovic M
ChemMedChem; 2018 Feb; 13(3):251-258. PubMed ID: 29235267
[TBL] [Abstract][Full Text] [Related]
14. Stepwise design, synthesis, and in vitro antifungal screening of (Z)-substituted-propenoic acid derivatives with potent broad-spectrum antifungal activity.
Khedr MA
Drug Des Devel Ther; 2015; 9():4501-13. PubMed ID: 26309398
[TBL] [Abstract][Full Text] [Related]
15. Lead optimization generates selenium-containing miconazole CYP51 inhibitors with improved pharmacological profile for the treatment of fungal infections.
Xu H; Yan ZZ; Guo MB; An R; Wang X; Zhang R; Mou YH; Hou Z; Guo C
Eur J Med Chem; 2021 Apr; 216():113337. PubMed ID: 33713977
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents.
Jiang Y; Zhang J; Cao Y; Chai X; Zou Y; Wu Q; Zhang D; Jiang Y; Sun Q
Bioorg Med Chem Lett; 2011 Aug; 21(15):4471-5. PubMed ID: 21737273
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of new fluconazole analogues.
Pore VS; Agalave SG; Singh P; Shukla PK; Kumar V; Siddiqi MI
Org Biomol Chem; 2015 Jun; 13(23):6551-61. PubMed ID: 25975803
[TBL] [Abstract][Full Text] [Related]
18. Potential dual inhibition of SE and CYP51 by eugenol conferring inhibition of Candida albicans: Computationally curated study with experimental validation.
Prajapati J; Goswami D; Dabhi M; Acharya D; Rawal RM
Comput Biol Med; 2022 Dec; 151(Pt A):106237. PubMed ID: 36327880
[TBL] [Abstract][Full Text] [Related]
19. De novo design of non-coordinating indolones as potential inhibitors for lanosterol 14-α-demethylase (CYP51).
González-Chávez R; Martínez R; Torre-Bouscoulet ME; Gallo M; González-Chávez MM
Chem Pharm Bull (Tokyo); 2014; 62(1):16-24. PubMed ID: 24390489
[TBL] [Abstract][Full Text] [Related]
20. Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis.
Friggeri L; Hargrove TY; Wawrzak Z; Blobaum AL; Rachakonda G; Lindsley CW; Villalta F; Nes WD; Botta M; Guengerich FP; Lepesheva GI
J Med Chem; 2018 Jul; 61(13):5679-5691. PubMed ID: 29894182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
